Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adipokines
25%
Adiponectin
25%
Advanced Disease
12%
Biomarker Panel
12%
Chronic Metabolic Disorder
12%
Circulating Levels
12%
Clinical Group
12%
Compartment-specific
12%
Control Disease
12%
Cytokine IL-6
12%
Cytokine Levels
12%
Diabetic Control
25%
Diabetic Kidney Disease
25%
Disease Monitoring
12%
Disease Stage
25%
Dyslipidemia
12%
Early Intervention
12%
Immune Regulatory Mechanism
12%
Immune-inflammatory Response
12%
Inflammation
100%
Inflammatory Cytokines
12%
Inflammatory Regulation
12%
Integrated Biomarker Response
12%
Interleukin-6
25%
Interleukin-8
37%
Leptin
37%
Logistic Regression
12%
MicroRNA
25%
MicroRNA-155 (miR-155)
37%
MiR-146a
37%
Non-diabetic
25%
Obesity
12%
Patient Stratification
12%
Patient Support
12%
Personalized Monitoring
12%
Poor Glycemic Control
12%
Renal Complications
12%
Risk Prediction
12%
ROC Analysis
12%
Serum-based
12%
Specific Analysis
12%
Strong Association
12%
Strong Predictor
12%
Subclinical Inflammation
12%
Type 2 Diabetes Mellitus (T2DM)
100%
Type 2 Diabetes Mellitus Patients
12%
Uncontrolled Type 2 Diabetes Mellitus
12%
Immunology and Microbiology
Adipokine
66%
Adiponectin
66%
Cytokine
33%
Glycemic Control
33%
Inflammation
100%
Inflammatory Cytokine
33%
Interleukin 6
100%
Interleukin 8
100%
Leptin
100%
Tumor Necrosis Factor
66%
Biochemistry, Genetics and Molecular Biology
Adipokine
20%
Adiponectin
20%
Cytokine
10%
Dyslipidemia
10%
Gene Linkage
100%
Glycemic Control
10%
Inflammatory Cytokine
10%
Interleukin 6
30%
Interleukin 8
30%
Leptin
30%
Maturity Onset Diabetes of the Young
100%
Metabolic Disorder
10%
MicroRNA
20%
MiR-155
30%
Tumor Necrosis Factor
20%